Sun Pharmaceutical Industries Ltd. - Research Center
524715 SUNPHARMA Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 15,585.98 | 12,803.21 | 12,531.93 | 10,303.21 | 7,947.60 |
| Operating profit | 2,907.52 | 2,936.00 | 2,711.65 | 1,756.26 | 123.02 |
| Interest | 388.10 | 256.98 | 408.01 | 540.92 | 388.31 |
| Gross profit | 3,477.34 | 2,829.24 | 3,814.56 | 2,486.78 | 862.75 |
| EPS (Rs) | -0.42 | 8.92 | 13.38 | 3.40 | -2.06 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | 957.92 | 150.22 | 1,510.92 | 1,271.44 | 1,128.04 |
| Stock adjustment | -183.18 | -214.84 | 138.60 | -251.30 | 159.26 |
| Raw material | 4,584.97 | 3,809.11 | 3,201.71 | 2,727.71 | 2,167.52 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2,000.78 | 1,798.45 | 1,702.77 | 1,571.34 | 1,617.69 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 6,275.89 | 4,474.49 | 4,777.20 | 4,499.20 | 3,880.11 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1,349.95 | 586.81 | 561.56 | 552.95 | 432.23 |
| Taxation | 406.85 | 13.17 | 41.86 | -97.15 | -25.39 |
| Net profit / loss | -99.99 | 2,139.70 | 3,211.14 | 816.60 | -494.59 |
| Extra ordinary item | -1,820.53 | -89.56 | - | -1,214.38 | -950.50 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 239.93 | 239.93 | 239.93 | 239.93 | 239.93 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 18.65 | 22.93 | 21.64 | 17.05 | 1.55 |
| GPM (%) | 21.02 | 21.84 | 27.16 | 21.48 | 9.51 |
| NPM (%) | -0.60 | 16.52 | 22.87 | 7.06 | -5.45 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis